Drug Shortage Report for SANDOZ D 10 000
Report ID | 225223 |
Drug Identification Number | 02253178 |
Brand name | SANDOZ D 10 000 |
Common or Proper name | D 10 000 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VITAMIN D3 |
Strength(s) | 10000UNIT |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 60SGC |
ATC code | A11CC |
ATC description | VIT A AND D, INCL COMBINATIONS OF THE TWO |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-04-15 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-04-16 | French | Compare |
v1 | 2024-04-16 | English | Compare |
Showing 1 to 2 of 2